Lucentis: Side Effects & Dosing

Lucentis

ranibizumab

Basic Prescribing Info

Contents

Ranibizumab

MIMS Class

Other Eye Preparations

ATC Classification

S01LA04 - ranibizumab ; Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Presentation/Packing

Form

Lucentis soln for inj 10 mg/mL

Packing/Price

0.23 mL x 1's

Already a member? Sign In